Androgens and body fat distribution

Journal of Steroid Biochemistry and Molecular Biology

Volumn 108, Issue 3-5, 2008, Pages 272-280

  Blouin, Karine ^a   Boivin, Ariane ^a   Tchernof, André ^a  

^a UNIVERSITÉ LAVAL   (Canada)

Author keywords

Adipocytes; Adipose Tissue; Androgens; Differentiation; Preadipocytes; Steroid aldoketoreductases; Steroidogenesis

Indexed keywords

ANDROGEN; ANDROSTANOLONE; FLUTAMIDE; GROWTH HORMONE; ISOPRENALINE; NANDROLONE DECANOATE; OXANDROLONE; PRASTERONE; SEX HORMONE BINDING GLOBULIN; SPIRONOLACTONE; TESTOSTERONE; TESTOSTERONE ENANTATE; TESTOSTERONE ESTER;

ABDOMINAL FAT; ABDOMINAL OBESITY; ADIPOCYTE; ADIPOGENESIS; ANDROGEN BLOOD LEVEL; ANDROGEN METABOLISM; ANDROGEN THERAPY; ARTICLE; BODY FAT DISTRIBUTION; CARDIOVASCULAR RISK; CASTRATION; CELL DIFFERENTIATION; CELL PROLIFERATION; COMPUTER ASSISTED TOMOGRAPHY; FEMALE TO MALE TRANSSEXUAL; HUMAN; HYPERANDROGENISM; HYPERINSULINEMIA; HYPOGONADISM; INTRAABDOMINAL FAT; LIPID TRANSPORT; LIPOGENESIS; LIPOLYSIS; METABOLIC SYNDROME X; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; OVARY POLYCYSTIC DISEASE; SEX DIFFERENCE; STEROIDOGENESIS; TESTOSTERONE BLOOD LEVEL;

ADIPOSE TISSUE; ANDROGENS; ANIMALS; BODY COMPOSITION; CELL LINE; FEMALE; HUMANS; MALE; SEX FACTORS; TESTOSTERONE;

EID: 38749133682     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2007.09.001     Document Type: Article

References (106)

1. Must A., Spadano J., Coakley E.H., Field A.E., Colditz G., and Dietz W.H. The disease burden associated with overweight and obesity. JAMA 282 16 (1999) 1523-1529
2. Lewis G.F., Carpentier A., Adeli K., and Giacca A. Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocr. Rev. 23 2 (2002) 201-229
3. Ravussin E., and Smith S.R. Increased fat intake, impaired fat oxidation, and failure of fat cell proliferation result in ectopic fat storage, insulin resistance, and type 2 diabetes mellitus. Ann. N. Y. Acad. Sci. 967 (2002) 363-378
4. Després J.P., Moorjani S., Lupien P.J., Tremblay A., Nadeau A., and Bouchard C. Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease. Arteriosclerosis 10 4 (1990) 497-511
5. Lemieux I., Pascot A., Prud'homme D., Almeras N., Bogaty P., Nadeau A., Bergeron J., and Després J.P. Elevated C-reactive protein: another component of the atherothrombotic profile of abdominal obesity. Arterioscler. Thromb. Vasc. Biol. 21 6 (2001) 961-967
6. Juhan-Vague I., Morange P.E., and Alessi M.C. The insulin resistance syndrome: implications for thrombosis and cardiovascular disease. Pathophysiol. Haemost. Thromb. 32 5-6 (2002) 269-273
7. Yusuf S., Hawken S., Ounpuu S., Dans T., Avezum A., Lanas F., McQueen M., Budaj A., Pais P., Varigos J., and Lisheng L. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364 9438 (2004) 937-952
8. Ross R., Shaw K.D., Rissanen J., Martel Y., de Guise J., and Avruch L. Sex differences in lean and adipose tissue distribution by magnetic resonance imaging: anthropometric relationships. Am. J. Clin. Nutr. 59 6 (1994) 1277-1285
9. Kuk J.L., Lee S., Heymsfield S.B., and Ross R. Waist circumference and abdominal adipose tissue distribution: influence of age and sex. Am. J. Clin. Nutr. 81 6 (2005) 1330-1334
10. Lemieux S., Prud'homme D., Bouchard C., Tremblay A., and Després J.P. Sex differences in the relation of visceral adipose tissue accumulation to total body fatness. Am. J. Clin. Nutr. 58 4 (1993) 463-467
11. Lemieux S., Després J.P., Moorjani S., Nadeau A., Theriault G., Prud'homme D., Tremblay A., Bouchard C., and Lupien P.J. Are gender differences in cardiovascular disease risk factors explained by the level of visceral adipose tissue?. Diabetologia 37 8 (1994) 757-764
12. Tchernof A., and Després J.P. Sex steroid hormones, sex hormone-binding globulin, and obesity in men and women. Horm. Metab. Res. 32 11-12 (2000) 526-536
13. Mayes J.S., and Watson G.H. Direct effects of sex steroid hormones on adipose tissues and obesity. Obes. Rev. 5 4 (2004) 197-216
14. Pasquali R., Casimirri F., Cantobelli S., Melchionda N., Morselli Labate A.M., Fabbri R., Capelli M., and Bortoluzzi L. Effect of obesity and body fat distribution on sex hormones and insulin in men. Metabolism 40 1 (1991) 101-104
15. Khaw K.T., and Barrett-Connor E. Lower endogenous androgens predict central adiposity in men. Ann. Epidemiol. 2 5 (1992) 675-682
16. Gapstur S.M., Gann P.H., Kopp P., Colangelo L., Longcope C., and Liu K. Serum androgen concentrations in young men: a longitudinal analysis of associations with age, obesity, and race. The CARDIA male hormone study. Cancer Epidemiol. Biomarkers Prev. 11 10 Pt 1 (2002) 1041-1047
17. Seidell J.C., Bjorntorp P., Sjostrom L., Kvist H., and Sannerstedt R. Visceral fat accumulation in men is positively associated with insulin, glucose, and C-peptide levels, but negatively with testosterone levels. Metabolism 39 9 (1990) 897-901
18. Couillard C., Gagnon J., Bergeron J., Leon A.S., Rao D.C., Skinner J.S., Wilmore J.H., Després J.P., and Bouchard C. Contribution of body fatness and adipose tissue distribution to the age variation in plasma steroid hormone concentrations in men: the HERITAGE Family Study. J. Clin. Endocrinol. Metab. 85 3 (2000) 1026-1031
19. Tchernof A., Després J.P., Bélanger A., Dupont A., Prud'homme D., Moorjani S., Lupien P.J., and Labrie F. Reduced testosterone and adrenal C19 steroid levels in obese men. Metabolism 44 4 (1995) 513-519
20. Garaulet M., Pérex-Llamas F., Fuente T., Zamora S., and Tebar F.J. Anthropometric, computed tomography and fat cell data in an obese population: relationship with insulin, leptin, tumor necrosis factor-alpha, sex hormone-binding globulin and sex hormones. Eur. J. Endocrinol. 143 5 (2000) 657-666
21. Tsai E.C., Matsumoto A.M., Fujimoto W.Y., and Boyko E.J. Association of bioavailable, free, and total testosterone with insulin resistance: influence of sex hormone-binding globulin and body fat. Diab. Care 27 4 (2004) 861-868
22. Hajamor S., Després J.P., Couillard C., Lemieux S., Tremblay A., Prud'homme D., and Tchernof A. Relationship between sex hormone-binding globulin levels and features of the metabolic syndrome. Metabolism 52 6 (2003) 724-730
23. Phillips G.B., Jing T., and Heymsfield S.B. Relationships in men of sex hormones, insulin, adiposity, and risk factors for myocardial infarction. Metabolism 52 6 (2003) 784-790
24. Blouin K., Després J.P., Couillard C., Tremblay A., Prud'homme D., Bouchard C., and Tchernof A. Contribution of age and declining androgen levels to features of the metabolic syndrome in men. Metabolism 54 8 (2005) 1034-1040
25. Laaksonen D.E., Niskanen L., Punnonen K., Nyyssonen K., Tuomainen T.P., Salonen R., Rauramaa R., and Salonen J.T. Sex hormones, inflammation and the metabolic syndrome: a population-based study. Eur. J. Endocrinol. 149 6 (2003) 601-608
26. Tchernof A., and Labrie F. Dehydroepiandrosterone, obesity and cardiovascular disease risk: a review of human studies. Eur. J. Endocrinol. 151 1 (2004) 1-14
27. Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr. Rev. 18 6 (1997) 774-800
28. Evans D.J., Barth J.H., and Burke C.W. Body fat topography in women with androgen excess. Int. J. Obes. 12 2 (1988) 157-162
29. Seidell J.C., Cigolini M., Charzewska J., Ellsinger B.M., Di Biase G., Bjorntorp P., Hautvast J.G., Contaldo F., Szostak V., and Scuro L.A. Androgenicity in relation to body fat distribution and metabolism in 38-year-old women-the European Fat Distribution Study. J. Clin. Epidemiol. 43 1 (1990) 21-34
30. Pedersen S.B., Borglum J.D., Brixen K., and Richelsen B. Relationship between sex hormones, body composition and metabolic risk parameters in premenopausal women. Eur. J. Endocrinol. 133 2 (1995) 200-206
31. Ivandic A., Prpic-Krizevac I., Bozic D., Barbir A., Peljhan V., Balog Z., and Glasnovic M. Insulin resistance and androgens in healthy women with different body fat distributions. Wien. Klin. Wochenschr. 114 8-9 (2002) 321-326
32. Kaye S.A., Folsom A.R., Soler J.T., Prineas R.J., and Potter J.D. Associations of body mass and fat distribution with sex hormone concentrations in postmenopausal women. Int. J. Epidemiol. 20 1 (1991) 151-156
33. De Pergola G., Triggiani V., Giorgino F., Cospite M.R., Garruti G., Cignarelli M., Guastamacchia E., and Giorgino R. The free testosterone to dehydroepiandrosterone sulphate molar ratio as a marker of visceral fat accumulation in premenopausal obese women. Int. J. Obes. Relat. Metab. Disord. 18 10 (1994) 659-664
34. Armellini F., Zamboni M., Castelli S., Robbi R., Mino A., Todesco T., Bergamo-Andreis I.A., and Bosello O. Interrelationships between intraabdominal fat and total serum testosterone levels in obese women. Metabolism 43 3 (1994) 390-395
35. Turcato E., Zamboni M., De Pergola G., Armellini F., Zivelonghi A., Bergamo-Andreis I.A., Giorgino R., and Bosello O. Interrelationships between weight loss, body fat distribution and sex hormones in pre- and postmenopausal obese women. J. Intern. Med. 241 5 (1997) 363-372
36. Tchernof A., Toth M.J., and Poehlman E.T. Sex hormone-binding globulin levels in middle-aged premenopausal women. Associations with visceral obesity and metabolic profile. Diab. Care 22 11 (1999) 1875-1881
37. Elbers J.M., Asscheman H., Seidell J.C., and Gooren L.J. Effects of sex steroid hormones on regional fat depots as assessed by magnetic resonance imaging in transsexuals. Am. J. Physiol. 276 2 Pt 1 (1999) E317-E325
38. Elbers J.M., Asscheman H., Seidell J.C., Megens J.A., and Gooren L.J. Long-term testosterone administration increases visceral fat in female to male transsexuals. J. Clin. Endocrinol. Metab. 82 7 (1997) 2044-2047
39. Elbers J.M., Giltay E.J., Teerlink T., Scheffer P.G., Asscheman H., Seidell J.C., and Gooren L.J. Effects of sex steroids on components of the insulin resistance syndrome in transsexual subjects. Clin. Endocrinol. (Oxf.) 58 5 (2003) 562-571
40. Boyanov M.A., Boneva Z., and Christov V.G. Testosterone supplementation in men with type 2 diabetes, visceral obesity and partial androgen deficiency. Aging Male 6 1 (2003) 1-7
41. Mårin P., Krotkiewski M., and Björntorp P. Androgen treatment of middle-aged, obese men: effects on metabolism, muscle and adipose tissues. Eur. J. Med. 1 6 (1992) 329-336
42. Mårin P. Testosterone and regional fat distribution. Obes. Res. 3 Suppl. 4 (1995) 609S-612S
43. Schroeder E.T., Zheng L., Ong M.D., Martinez C., Flores C., Stewart Y., Azen C., and Sattler F.R. Effects of androgen therapy on adipose tissue and metabolism in older men. J. Clin. Endocrinol. Metab. 89 10 (2004) 4863-4872
44. Lovejoy J.C., Bray G.A., Greeson C.S., Klemperer M., Morris J., Partington C., and Tulley R. Oral anabolic steroid treatment, but not parenteral androgen treatment, decreases abdominal fat in obese, older men. Int. J. Obes. Relat. Metab. Disord. 19 9 (1995) 614-624
45. Munzer T., Harman S.M., Hees P., Shapiro E., Christmas C., Bellantoni M.F., Stevens T.E., O'Connor K.G., Pabst K.M., St Clair C., Sorkin J.D., and Blackman M.R. Effects of GH and/or sex steroid administration on abdominal subcutaneous and visceral fat in healthy aged women and men. J. Clin. Endocrinol. Metab. 86 8 (2001) 3604-3610
46. Woodhouse L.J., Gupta N., Bhasin M., Singh A.B., Ross R., Phillips J., and Bhasin S. Dose-dependent effects of testosterone on regional adipose tissue distribution in healthy young men. J. Clin. Endocrinol. Metab. 89 2 (2004) 718-726
47. Glazer G. Atherogenic effects of anabolic steroids on serum lipid levels. A literature review. Arch. Intern. Med. 151 10 (1991) 1925-1933
48. Elbers J.M., de Jong S., Teerlink T., Asscheman H., Seidell J.C., and Gooren L.J. Changes in fat cell size and in vitro lipolytic activity of abdominal and gluteal adipocytes after a one-year cross-sex hormone administration in transsexuals. Metabolism 48 11 (1999) 1371-1377
49. Rebuffé-Scrive M., Mårin P., and Björntorp P. Effect of testosterone on abdominal adipose tissue in men. Int. J. Obes. 15 11 (1991) 791-795
50. Mårin P., Odén B., and Björntorp P. Assimilation and mobilization of triglycerides in subcutaneous abdominal and femoral adipose tissue in vivo in men: effects of androgens. J. Clin. Endocrinol. Metab. 80 1 (1995) 239-243
51. Mårin P., Lönn L., Andersson B., Odén B., Olbe L., Bengtsson B.A., and Björntorp P. Assimilation of triglycerides in subcutaneous and intraabdominal adipose tissues in vivo in men: effects of testosterone. J. Clin. Endocrinol. Metab. 81 3 (1996) 1018-1022
52. Lovejoy J.C., Bray G.A., Bourgeois M.O., Macchiavelli R., Rood J.C., Greeson C., and Partington C. Exogenous androgens influence body composition and regional body fat distribution in obese postmenopausal women-a clinical research center study. J. Clin. Endocrinol. Metab. 81 6 (1996) 2198-2203
53. Lanfranco F., Zitzmann M., Simoni M., and Nieschlag E. Serum adiponectin levels in hypogonadal males: influence of testosterone replacement therapy. Clin. Endocrinol. (Oxf.) 60 4 (2004) 500-507
54. Page S.T., Herbst K.L., Amory J.K., Coviello A.D., Anawalt B.D., Matsumoto A.M., and Bremner W.J. Testosterone administration suppresses adiponectin levels in men. J. Androl. 26 1 (2005) 85-92
55. Jockenhovel F., Blum W.F., Vogel E., Englaro P., Muller-Wieland D., Reinwein D., Rascher W., and Krone W. Testosterone substitution normalizes elevated serum leptin levels in hypogonadal men. J. Clin. Endocrinol. Metab. 82 8 (1997) 2510-2513
56. Malkin C.J., Pugh P.J., Jones R.D., Kapoor D., Channer K.S., and Jones T.H. The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men. J. Clin. Endocrinol. Metab. 89 7 (2004) 3313-3318
57. Giltay E.J., Elbers J.M., Gooran L.J., Emeis J.J., Kooistra T., Asscheman H., and Stehouwer C.D. Visceral fat accumulation is an important determinant of PAI-1 levels in young, nonobese men and women: modulation by cross-sex hormone administration, Arterioscler. Thromb. Vasc. Biol. 18 11 (1998) 1716-1722
58. Sato T., Matsumoto T., Yamada T., Watanabe T., Kawano H., and Kato S. Late onset of obesity in male androgen receptor-deficient (AR KO) mice. Biochem. Biophys. Res. Commun. 300 1 (2003) 167-171
59. Fan W., Yanase T., Nomura M., Okabe T., Goto K., Sato T., Kawano H., Kato S., and Nawata H. Androgen receptor null male mice develop late-onset obesity caused by decreased energy expenditure and lipolytic activity but show normal insulin sensitivity with high adiponectin secretion. Diabetes 54 4 (2005) 1000-1008
60. Li M., and Björntorp P. Effects of testosterone on triglyceride uptake and mobilization in different adipose tissues in male rats in vivo. Obes. Res. 3 2 (1995) 113-119
61. Dieudonné M.N., Pecquery R., Leneveu M.C., and Giudicelli Y. Opposite effects of androgens and estrogens on adipogenesis in rat preadipocytes: evidence for sex and site-related specificities and possible involvement of insulin-like growth factor 1 receptor and peroxisome proliferator-activated receptor gamma2. Endocrinology 141 2 (2000) 649-656
62. Monjo M., Pujol E., and Roca P. alpha2- to beta3-Adrenoceptor switch in 3T3-L1 preadipocytes and adipocytes: modulation by testosterone, 17beta-estradiol, and progesterone. Am. J. Physiol. Endocrinol. Metab. 289 1 (2005) E145-E150
63. Anderson L.A., McTernan P.G., Barnett A.H., and Kumar S. The effects of androgens and estrogens on preadipocyte proliferation in human adipose tissue: influence of gender and site. J. Clin. Endocrinol. Metab. 86 10 (2001) 5045-5051
64. Lacasa D., Agli B., Moynard D., and Giudicelli Y. Evidence for a regional-specific control of rat preadipocyte proliferation and differentiation by the androgenic status. Endocrine 3 11 (1995) 789-793
65. Lacasa D., Garcia E., Henriot D., Agli B., and Giudicelli Y. Site-related specificities of the control by androgenic status of adipogenesis and mitogen-activated protein kinase cascade/c-fos signaling pathways in rat preadipocytes. Endocrinology 138 8 (1997) 3181-3186
66. Singh R., Artaza J.N., Taylor W.E., Gonzalez-Cadavid N.F., and Bhasin S. Androgens stimulate myogenic differentiation and inhibit adipogenesis in C3H 10T1/2 pluripotent cells through an androgen receptor-mediated pathway. Endocrinology 144 11 (2003) 5081-5088
67. Singh R., Artaza J.N., Taylor W.E., Braga M., Yuan X., Gonzalez-Cadavid N.F., and Bhasin S. Testosterone inhibits adipogenic differentiation in 3T3-L1 cells: nuclear translocation of androgen receptor complex with beta-catenin and T-cell factor 4 may bypass canonical Wnt signaling to down-regulate adipogenic transcription factors. Endocrinology 147 1 (2006) 141-154
68. Dicker A., Ryden M., Naslund E., Muehlen I.E., Wiren M., Lafontan M., and Arner P. Effect of testosterone on lipolysis in human pre-adipocytes from different fat depots. Diabetologia 47 3 (2004) 420-428
69. Rodriguez-Cuenca S., Monjo M., Proenza A.M., and Roca P. Depot differences in steroid receptor expression in adipose tissue: possible role of the local steroid milieu. Am. J. Physiol. Endocrinol. Metab. 288 1 (2005) E200-E207
70. Jaubert A.-M., Pecquery R., Sichez I., Dieudonné M.N., Cloix J.F., and Giudicelli Y. Androgen receptors in hamster white adipocytes and their precursor cells: regional variations and modulation by androgens. Endocrine J. 1 (1993) 535-540
71. Dieudonné M.N., Pecquery R., Boumediene A., Leneveu M.C., and Giudicelli Y. Androgen receptors in human preadipocytes and adipocytes: regional specificities and regulation by sex steroids. Am. J. Physiol. 274 6 Pt 1 (1998) C1645-C1652
72. Joyner J., Hutley L., and Cameron D. Intrinsic regional differences in androgen receptors and dihydrotestosterone metabolism in human preadipocytes. Horm. Metab. Res. 34 5 (2002) 223-228
73. De Pergola G., Xu X.F., Yang S.M., Giorgino R., and Bjorntorp P. Up-regulation of androgen receptor binding in male rat fat pad adipose precursor cells exposed to testosterone: study in a whole cell assay system. J. Steroid. Biochem. Mol. Biol. 37 4 (1990) 553-558
74. Pecquery R., Dieudonné M.N., Cloix J.F., Leneveu M.C., Dausse J.P., and Giudicelli Y. Enhancement of the expression of the alpha 2-adrenoreceptor protein and mRNA by a direct effect of androgens in white adipocytes. Biochem. Biophys. Res. Commun. 206 1 (1995) 112-118
75. Garcia E., Lacasa M., Agli B., Giudicelli Y., and Lacasa D. Modulation of rat preadipocyte adipose conversion by androgenic status: involvement of C/EBPs transcription factors. J. Endocrinol. 161 1 (1999) 89-97
76. Xu X., De Pergola G., and Björntorp P. The effects of androgens on the regulation of lipolysis in adipose precursor cells. Endocrinology 126 2 (1990) 1229-1234
77. Hansen F.M., Fahmy N., and Nielsen J.H. The influence of sexual hormones on lipogenesis and lipolysis in rat fat cells. Acta Endocrinol. (Copenh.) 95 4 (1980) 566-570
78. Pecquery R., Leneveu M.C., and Giudicelli Y. Influence of androgenic status on the alpha 2/beta-adrenergic control of lipolysis in white fat cells: predominant alpha 2-antilipolytic response in testosterone-treated-castrated hamsters. Endocrinology 122 6 (1988) 2590-2596
79. Xu X.F., De Pergola G., and Björntorp P. Testosterone increases lipolysis and the number of beta-adrenoceptors in male rat adipocytes. Endocrinology 128 1 (1991) 379-382
80. Anderson L.A., McTernan P.G., Harte A.L., Barnett A.H., and Kumar S. The regulation of HSL and LPL expression by DHT and flutamide in human subcutaneous adipose tissue. Diabetes Obes. Metab. 4 3 (2002) 209-213
81. Xu X., De Pergola G., Eriksson P.S., Fu L., Carlsson B., Yang S., Edén S., and Björntorp P. Postreceptor events involved in the up-regulation of beta-adrenergic receptor mediated lipolysis by testosterone in rat white adipocytes. Endocrinology 132 4 (1993) 1651-1657
82. Lacasa D., Denis D., Agli B., de Mazancourt P., and Giudicelli Y. Rat preadipocyte adenylyl cyclase: influence of fat localization and androgenic status. Biochim. Biophys. Acta 1224 3 (1994) 527-532
83. Lacasa D., Agli B., Mur B., Dieudonné M.N., and Giudicelli Y. Protein kinase in rat adipocytes: influence of androgenic status and regional fat distribution. J. Endocrinol. 138 3 (1993) 493-501
84. Dieudonné M.N., Pecquery R., Dausse J.P., and Giudicelli Y. Regulation of white adipocyte guanine nucleotide binding proteins Gs alpha and Gi alpha 1-2 by testosterone in vivo: influence of regional fat distribution. Biochim. Biophys. Acta 1176 1-2 (1993) 123-127
85. Bouloumie A., Valet P., Dauzats M., Lafontan M., and Saulnier-Blache J.S. In vivo upregulation of adipocyte alpha 2-adrenoceptors by androgens is consequence of direct action on fat cells. Am. J. Physiol. 267 4 Pt 1 (1994) C926-C931
86. Saulnier-Blache J.S., Bouloumie A., Valet P., Devedjian J.C., and Lafontan M. Androgenic regulation of adipocyte alpha 2-adrenoceptor expression in male and female Syrian hamsters: proposed transcriptional mechanism. Endocrinology 130 1 (1992) 316-327
87. Machinal-Quelin F., Dieudonné M.N., Pecquery R., Leneveu M.C., and Giudicelli Y. Direct in vitro effects of androgens and estrogens on ob gene expression and leptin secretion in human adipose tissue. Endocrine 18 2 (2002) 179-184
88. Nishizawa H., Shimomura I., Kishida K., Maeda N., Kuriyama H., Nagaretani H., Matsuda M., Kondo H., Furuyama N., Kihara S., Nakamura T., Tochino Y., Funahashi T., and Matsuzawa Y. Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. Diabetes 51 9 (2002) 2734-2741
89. Serazin-Leroy V., Morot M., de Mazancourt P., and Giudicelli Y. Androgen regulation and site specificity of angiotensinogen gene expression and secretion in rat adipocytes. Am. J. Physiol. Endocrinol. Metab. 279 6 (2000) E1398-E1405
90. Labrie F., and Intracrinology. Mol. Cell. Endocrinol. 78 3 (1991) C113-C118
91. Bélanger C., Luu-The V., Dupont P., and Tchernof A. Adipose tissue intracrinology: potential importance of local androgen/estrogen metabolism in the regulation of adiposity. Horm. Metab. Res. 34 11-12 (2002) 737-745
92. Tchernof A., Labrie F., Bélanger A., Prud'homme D., Bouchard C., Tremblay A., Nadeau A., and Després J.P. Androstane-3alpha,17beta-diol glucuronide as a steroid correlate of visceral obesity in men. J. Clin. Endocrinol. Metab. 82 5 (1997) 1528-1534
93. Pritchard J., Després J.P., Gagnon J., Tchernof A., Nadeau A., Tremblay A., and Bouchard C. Plasma adrenal, gonadal, and conjugated steroids before and after long-term overfeeding in identical twins. J. Clin. Endocrinol. Metab. 83 9 (1998) 3277-3284
94. Pritchard J., Després J.P., Gagnon J., Tchernof A., Nadeau A., Tremblay A., and Bouchard C. Plasma adrenal, gonadal, and conjugated steroids following long-term exercise-induced negative energy balance in identical twins. Metabolism 48 9 (1999) 1120-1127
95. Blanchette S., Blouin K., Richard C., Dupont P., Luu-The V., and Tchernof A. Expression and activity of 20alpha-hydroxysteroid dehydrogenase (AKR1C1) in abdominal subcutaneous and omental adipose tissue in women. J. Clin. Endocrinol. Metab. 90 1 (2005) 264-270
96. Blouin K., Richard C., Bélanger C., Dupont P., Daris M., Laberge P., Luu-The V., and Tchernof A. Local androgen inactivation in abdominal visceral adipose tissue. J. Clin. Endocrinol. Metab. 88 12 (2003) 5944-5950
97. Blouin K., Blanchette S., Richard C., Dupont P., Luu-The V., and Tchernof A. Expression and activity of steroid aldoketoreductases 1C in omental adipose tissue are positive correlates of adiposity in women. Am. J. Physiol. Endocrinol. Metab. 288 2 (2005) E398-E404
98. Blouin K., Richard C., Brochu G., Hould F.S., Lebel S., Marceau S., Biron S., Luu-The V., and Tchernof A. Androgen inactivation and steroid-converting enzyme expression in abdominal adipose tissue in men. J. Endocrinol. 191 3 (2006) 637-649
99. Bélanger C., Hould F.S., Lebel S., Biron S., Brochu G., and Tchernof A. Omental and subcutaneous adipose tissue steroid levels in obese men. Steroids 71 8 (2006) 674-682
100. Killinger D.W., Perel E., Danilescu D., Kharlip L., and Lindsay W.R. Influence of adipose tissue distribution on the biological activity of androgens. Ann. N. Y. Acad. Sci. 595 (1990) 199-211
101. Dieudonné M.N., Sammari A., Dos Santos E., Leneveu M.C., Giudicelli Y., and Pecquery R. Sex steroids and leptin regulate 11beta-hydroxysteroid dehydrogenase I and P450 aromatase expressions in human preadipocytes: Sex specificities. J. Steroid Biochem. Mol. Biol. 99 4-5 (2006) 189-196
102. Longcope C., and Fineberg S.E. Production and metabolism of dihydrotestosterone in peripheral tissues. J. Steroid Biochem. 23 4 (1985) 415-419
103. Quinkler M., Sinha B., Tomlinson J.W., Bujalska I.J., Stewart P.M., and Arlt W. Androgen generation in adipose tissue in women with simple obesity-a site-specific role for 17beta-hydroxysteroid dehydrogenase type 5. J. Endocrinol. 183 2 (2004) 331-342
104. Masuzaki H., Paterson J., Shinyama H., Morton N.M., Mullins J.J., Seckl J.R., and Flier J.S. A transgenic model of visceral obesity and the metabolic syndrome. Science 294 5549 (2001) 2166-2170
105. Jones M.E., Thorburn A.W., Britt K.L., Hewitt K.N., Wreford N.G., Proietto J., Oz O.K., Leury B.J., Robertson K.M., Yao S., and Simpson E.R. Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity. Proc. Natl. Acad. Sci. U.S.A. 97 23 (2000) 12735-12740
106. Misso M.L., Murata Y., Boon W.C., Jones M.E., Britt K.L., and Simpson E.R. Cellular and molecular characterization of the adipose phenotype of the aromatase-deficient mouse. Endocrinology 144 4 (2003) 1474-1480